Interpretable AI model could offer new insights into why medicines cause certain side effects, helping to improve future drug safety predictions.
Machine learning and statistical prediction of overall survival (OS) from pre-dose plasma biomarkers in a randomized phase 2 trial (1801 Part 3B) of the GSK-3 inhibitor elraglusib in metastatic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results